ANI Pharmaceuticals offers SEK 11.25 per share, about $560M, to acquire Egetis Therapeutics

ANI Pharmaceuticals announced an offer at SEK 11.25 per share, about SEK 5.6 billion ($560 million), to acquire Egetis Therapeutics, expanding its rare disease business.

Detected & updated continuously · Source: Nebula